Normal view MARC view ISBD view

Autologous stem cell transplantation for acute myeloid leukemia

In Bone Marrow Transplantation
By: Linker, C A.
Contributor(s): .
Material type: materialTypeLabelArticleSeries: Vol 31 Issues.Publisher: 2003Description: 731-738.Subject(s): LeukemiaDDC classification: 616.155 In: Bone Marrow TransplantationSummary: The collection of stem cells during recovery from intensive dose consolidation therapy appears to be an attractive strategy that can increase the percentage of patients who are able to receive their intended transplant. Consolidation therapy prior tostem cell collection and transplant has been shown to decrease the relapse rate and improve outcomes, but the optimal nature of this consolidation therapy is unknown.For patients with AML in second remission, ABMT/ASCT offers a substantial salvage rate, and is particularly effective for patients with acute promyelocytic leukemia.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
616.155 Available AR4561

The collection of stem cells during recovery from intensive dose consolidation therapy appears to be an attractive strategy that can increase the percentage of patients who are able to receive their intended transplant. Consolidation therapy prior tostem cell collection and transplant has been shown to decrease the relapse rate and improve outcomes, but the optimal nature of this consolidation therapy is unknown.For patients with AML in second remission, ABMT/ASCT offers a substantial salvage rate, and is particularly effective for patients with acute promyelocytic leukemia.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha